GBT

Global Blood Therapeutics, Inc.
GBT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

59 hedge funds and large institutions have $1.12B invested in Global Blood Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$622M
2
+$186M
3
+$38.9M
4
DM
Deerfield Management
New York
+$37.5M
5
PHS
PFM Health Sciences
California
+$32M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$622M
2
$186M
3
$38.9M
4
$37.5M
5
$32M
6
$28.3M
7
$19.3M
8
$15.6M
9
$14.5M
10
$13.4M
11
$11.1M
12
$10.3M
13
$9.01M
14
$8.43M
15
$8.12M
16
$6.95M
17
$6.81M
18
$4.91M
19
$3.9M
20
$3.63M
21
$3.17M
22
$3.16M
23
$3.04M
24
$2.74M
25
$2.66M
1
2 3